These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. A customized genetic approach to the number one killer: coronary artery disease. Roberts R Curr Opin Cardiol; 2008 Nov; 23(6):629-33. PubMed ID: 18830080 [TBL] [Abstract][Full Text] [Related]
28. Identification of novel SNPs associated with coronary artery disease and birth weight using a pleiotropic cFDR method. Wu X; Lin X; Li Q; Wang Z; Zhang N; Tian M; Wang X; Deng H; Tan H Aging (Albany NY); 2020 Dec; 13(3):3618-3644. PubMed ID: 33411684 [TBL] [Abstract][Full Text] [Related]
29. Functional Analysis of a Novel Genome-Wide Association Study Signal in SMAD3 That Confers Protection From Coronary Artery Disease. Turner AW; Martinuk A; Silva A; Lau P; Nikpay M; Eriksson P; Folkersen L; Perisic L; Hedin U; Soubeyrand S; McPherson R Arterioscler Thromb Vasc Biol; 2016 May; 36(5):972-83. PubMed ID: 26966274 [TBL] [Abstract][Full Text] [Related]
30. Identification of susceptibility modules for coronary artery disease using a genome wide integrated network analysis. Duan S; Luo X; Dong C Gene; 2013 Dec; 531(2):347-54. PubMed ID: 23994195 [TBL] [Abstract][Full Text] [Related]
31. Genome-wide significant loci: how important are they? Systems genetics to understand heritability of coronary artery disease and other common complex disorders. Björkegren JLM; Kovacic JC; Dudley JT; Schadt EE J Am Coll Cardiol; 2015 Mar; 65(8):830-845. PubMed ID: 25720628 [TBL] [Abstract][Full Text] [Related]
32. Apolipoprotein A-I concentrations and risk of coronary artery disease: A Mendelian randomization study. Karjalainen MK; Holmes MV; Wang Q; Anufrieva O; Kähönen M; Lehtimäki T; Havulinna AS; Kristiansson K; Salomaa V; Perola M; Viikari JS; Raitakari OT; Järvelin MR; Ala-Korpela M; Kettunen J Atherosclerosis; 2020 Apr; 299():56-63. PubMed ID: 32113648 [TBL] [Abstract][Full Text] [Related]
33. Polygenic risk for coronary artery disease in the Scottish and English population. Yang C; Starnecker F; Pang S; Chen Z; Güldener U; Li L; Heinig M; Schunkert H BMC Cardiovasc Disord; 2021 Dec; 21(1):586. PubMed ID: 34876023 [TBL] [Abstract][Full Text] [Related]
34. The impact of susceptibility loci for coronary artery disease on other vascular domains and recurrence risk. Tragante V; Doevendans PA; Nathoe HM; van der Graaf Y; Spiering W; Algra A; de Borst GJ; de Bakker PI; Asselbergs FW; Eur Heart J; 2013 Oct; 34(37):2896-904. PubMed ID: 23828831 [TBL] [Abstract][Full Text] [Related]
39. Genome-wide association study on coronary artery disease in type 1 diabetes suggests beta-defensin 127 as a risk locus. Antikainen AAV; Sandholm N; Trégouët DA; Charmet R; McKnight AJ; Ahluwalia TS; Syreeni A; Valo E; Forsblom C; Gordin D; Harjutsalo V; Hadjadj S; Maxwell AP; Rossing P; Groop PH Cardiovasc Res; 2021 Jan; 117(2):600-612. PubMed ID: 32077919 [TBL] [Abstract][Full Text] [Related]
40. Genetics-Current and Future Role in the Prevention and Management of Coronary Artery Disease. Roberts R Curr Atheroscler Rep; 2016 Dec; 18(12):78. PubMed ID: 27815829 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]